InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa
28 avr. 2021 07h30 HE
|
InMed Pharmaceuticals Inc.
Filings submitted in Austria, Israel, and Serbia for a Phase 2 Clinical Trial with INM-755 creamAdditional submissions slated for France, Germany, Greece, and Italy over the next several days and...
InMed Pharmaceuticals Announces Voluntary Delisting from TSX
27 avr. 2021 07h30 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq:INM) (TSX:IN), a clinical-stage company developing cannabinoid-based...
InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™
26 avr. 2021 07h30 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...
InMed to Present at Virtual Conferences in March 2021
03 mars 2021 18h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...
InMed Pharmaceuticals announces increase in Bought Deal offering to $13 million
12 juin 2018 09h54 HE
|
InMed Pharmaceuticals Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2018 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (TSX:IN)...
InMed Pharmaceuticals Announces $10 Million Bought Deal
12 juin 2018 07h30 HE
|
InMed Pharmaceuticals Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, B.C., June 12, 2018 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (TSX:IN) (“InMed”...
InMed Pharmaceuticals Announces Marketed Offering of Common Shares
21 avr. 2017 05h30 HE
|
InMed Pharmaceuticals, Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2017) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
InMed...
InMed Announces Appointment of Eric A. Adams as CEO, President and Director
16 juin 2016 09h02 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 16, 2016) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing...
InMed Announces Update on Biosynthesis Project
16 févr. 2016 06h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 16, 2016) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company...
InMed Strengthens Board With Appointment of Experienced Biotech Executive Adam Cutler
23 nov. 2015 06h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 23, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the research and...